Last reviewed · How we verify
Rivaroxaban granules for oral suspension
Rivaroxaban granules for oral suspension is a Small molecule drug developed by Bayer. It is currently in Phase 2 development. Also known as: Xarelto, BAY59-7939.
At a glance
| Generic name | Rivaroxaban granules for oral suspension |
|---|---|
| Also known as | Xarelto, BAY59-7939 |
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
- A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men (PHASE1)
- A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants (PHASE1)
- Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children (PHASE1)
- Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rivaroxaban granules for oral suspension CI brief — competitive landscape report
- Rivaroxaban granules for oral suspension updates RSS · CI watch RSS
- Bayer portfolio CI
Frequently asked questions about Rivaroxaban granules for oral suspension
What is Rivaroxaban granules for oral suspension?
Rivaroxaban granules for oral suspension is a Small molecule drug developed by Bayer.
Who makes Rivaroxaban granules for oral suspension?
Rivaroxaban granules for oral suspension is developed by Bayer (see full Bayer pipeline at /company/bayer).
Is Rivaroxaban granules for oral suspension also known as anything else?
Rivaroxaban granules for oral suspension is also known as Xarelto, BAY59-7939.
What development phase is Rivaroxaban granules for oral suspension in?
Rivaroxaban granules for oral suspension is in Phase 2.
Related
- Manufacturer: Bayer — full pipeline
- Also known as: Xarelto, BAY59-7939
- Compare: Rivaroxaban granules for oral suspension vs similar drugs
- Pricing: Rivaroxaban granules for oral suspension cost, discount & access